Cargando…

Hydrogel-Based Microneedle as a Drug Delivery System

The skin is considered the largest and most accessible organ in the human body, and allows the use of noninvasive and efficient strategies for drug administration, such as the transdermal drug delivery system (TDDS). TDDSs are systems or patches, with the ability and purpose to deliver effective and...

Descripción completa

Detalles Bibliográficos
Autores principales: Filho, David, Guerrero, Marcelo, Pariguana, Manuel, Marican, Adolfo, Durán-Lara, Esteban F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609870/
https://www.ncbi.nlm.nih.gov/pubmed/37896204
http://dx.doi.org/10.3390/pharmaceutics15102444
_version_ 1785128116600963072
author Filho, David
Guerrero, Marcelo
Pariguana, Manuel
Marican, Adolfo
Durán-Lara, Esteban F.
author_facet Filho, David
Guerrero, Marcelo
Pariguana, Manuel
Marican, Adolfo
Durán-Lara, Esteban F.
author_sort Filho, David
collection PubMed
description The skin is considered the largest and most accessible organ in the human body, and allows the use of noninvasive and efficient strategies for drug administration, such as the transdermal drug delivery system (TDDS). TDDSs are systems or patches, with the ability and purpose to deliver effective and therapeutic doses of drugs through the skin. Regarding the specific interaction between hydrogels (HG) and microneedles (MNs), we seek to find out how this combination would be applied in the context of drug delivery, and we detail some possible advantages of the methods used. Depending on the components belonging to the HG matrix, we can obtain some essential characteristics that make the combination of hydrogels–microneedles (HG–MNs) very advantageous, such as the response to external stimuli, among others. Based on multiple characteristics provided by HGMNs that are depicted in this work, it is possible to obtain unique properties that include controlled, sustained, and localized drug release, as well as the possibility of a synergistic association between the components of the formulation and the combination of more than one bioactive component. In conclusion, a system based on HG–MNs can offer many advantages in the biomedical field, bringing to light a new technological and safe system for improving the pharmacokinetics and pharmacodynamics of drugs and new treatment perspectives.
format Online
Article
Text
id pubmed-10609870
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106098702023-10-28 Hydrogel-Based Microneedle as a Drug Delivery System Filho, David Guerrero, Marcelo Pariguana, Manuel Marican, Adolfo Durán-Lara, Esteban F. Pharmaceutics Review The skin is considered the largest and most accessible organ in the human body, and allows the use of noninvasive and efficient strategies for drug administration, such as the transdermal drug delivery system (TDDS). TDDSs are systems or patches, with the ability and purpose to deliver effective and therapeutic doses of drugs through the skin. Regarding the specific interaction between hydrogels (HG) and microneedles (MNs), we seek to find out how this combination would be applied in the context of drug delivery, and we detail some possible advantages of the methods used. Depending on the components belonging to the HG matrix, we can obtain some essential characteristics that make the combination of hydrogels–microneedles (HG–MNs) very advantageous, such as the response to external stimuli, among others. Based on multiple characteristics provided by HGMNs that are depicted in this work, it is possible to obtain unique properties that include controlled, sustained, and localized drug release, as well as the possibility of a synergistic association between the components of the formulation and the combination of more than one bioactive component. In conclusion, a system based on HG–MNs can offer many advantages in the biomedical field, bringing to light a new technological and safe system for improving the pharmacokinetics and pharmacodynamics of drugs and new treatment perspectives. MDPI 2023-10-10 /pmc/articles/PMC10609870/ /pubmed/37896204 http://dx.doi.org/10.3390/pharmaceutics15102444 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Filho, David
Guerrero, Marcelo
Pariguana, Manuel
Marican, Adolfo
Durán-Lara, Esteban F.
Hydrogel-Based Microneedle as a Drug Delivery System
title Hydrogel-Based Microneedle as a Drug Delivery System
title_full Hydrogel-Based Microneedle as a Drug Delivery System
title_fullStr Hydrogel-Based Microneedle as a Drug Delivery System
title_full_unstemmed Hydrogel-Based Microneedle as a Drug Delivery System
title_short Hydrogel-Based Microneedle as a Drug Delivery System
title_sort hydrogel-based microneedle as a drug delivery system
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609870/
https://www.ncbi.nlm.nih.gov/pubmed/37896204
http://dx.doi.org/10.3390/pharmaceutics15102444
work_keys_str_mv AT filhodavid hydrogelbasedmicroneedleasadrugdeliverysystem
AT guerreromarcelo hydrogelbasedmicroneedleasadrugdeliverysystem
AT pariguanamanuel hydrogelbasedmicroneedleasadrugdeliverysystem
AT maricanadolfo hydrogelbasedmicroneedleasadrugdeliverysystem
AT duranlaraestebanf hydrogelbasedmicroneedleasadrugdeliverysystem